Drug Interactions between sunitinib and Unasyn
This report displays the potential drug interactions for the following 2 drugs:
- Unasyn (ampicillin/sulbactam)
Interactions between your drugs
There were no interactions found in our database between sunitinib and Unasyn - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Sunitinib is in the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors.
- Sunitinib is used to treat the following conditions:
- Unasyn is a member of the drug class beta-lactamase inhibitors.
- Unasyn is used to treat the following conditions:
- Aspiration Pneumonia
- Bacterial Infection
- Bone infection
- Deep Neck Infection
- Intraabdominal Infection
- Joint Infection
- Kidney Infections
- Pelvic Inflammatory Disease
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Surgical Prophylaxis
- Urinary Tract Infection
Drug and food interactions
Applies to: Unasyn (ampicillin / sulbactam)
You may experience reduced absorption of ampicillin in the presence of food. The effectiveness of the antibiotic may be reduced. Ampicillin should be administered one hour before or two hours after meals. This will make it easier for your body to absorb the medication. Penicillin V and amoxicillin are not affected by food and may be given without regard to meals.
Applies to: sunitinib
SUNItinib may be taken with or without food. If you are receiving therapy with SUNItinib you should avoid the regular consumption of large amounts of grapefruits and grapefruit juice. Grapefruit can raise the levels of SUNItinib in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.